Breast cancer incidence is rising among U.S. women under 50, according to new research published in JAMA Network Open [1].Read More

A recently developed pretargeted radioimmunotherapy (PRIT) system has displayed potential in treating advanced epithelial ovarian cancer with limited side effects. This therapy, known as anti-HER2 225Ac-PRIT, specifically targets a protein commonly found

“Immediate attention” is needed to address cancer diagnosis deficits stemming from the COVID-19 health crisis, researchers charged in a new analysis published Tuesday in JAMA Network Open [1]

Experts are touting the benefits of an intensive follow-up regimen for head and neck squamous cell carcinoma (HNSCC) using PET/CT.

Radiotherapy is one of the main treatment modalities in cancer management, often used in combination with other treatments, such as surgery or chemotherapy. Approximately 40% of cancer cures are attributed to radiotherapy. Read the full report now